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VISUALISATION OF OSTEOPROGENITOR CELLS IN A PRX1 MURINE 
FRACTURE MODEL 
BLAIRE M. BEERS-MULROY  
ABSTRACT  Understanding the recruitment of multipotent skeletal progenitor cells and the 
factors that influence their differentiation would be helpful in providing a means for 
harnessing the regenerative capacity of skeletal progenitor cells in bone tissue 
engineering. In order to track the recruitment of skeletal stem cells in fracture healing, 
transgenic mice containing a Tamoxifen-inducible Cre recombinase that had been placed 
under the control of a 2.4 kb Prx1 promotor were used to induce conditional expression in 
periosteal skeletal stem cells that express the Prx1 gene. In order to initially see the cells 
expressing Prx1, a green fluorescent protein gene (GFP) had also been put downstream to 
the Prx1 promotor. We then crossed these Prx1CreER-GFP transgenic mice with a 
second strain containing the β-galactosidase gene that becomes constitutively expressed 
after recombination by the Cre recombinase. The enzymatic activity of β-galactosidase 
was then used to generate a colormetric staining reaction that was used to visualize the 
cells in which recombination had occurred based on a blue staining product. The 
recombination activity should only be present in Prx1 expressing cells and their progeny.  
 The goal of the present study was to assess several different approaches to 
optimize the β-galactosidase enzymatic staining protocol and to visualize the Prx1 
expressing cells during fracture healing. These studies further examined those 
populations of cells in the fracture calluses that became labeled and arose from the stem  iv 
 
cell populations that had expressed Prx1 at post-operative day 7 and 14. The optimization 
of a staining method for histology will allow this study to track Prx1 cell fates in a 
fracture model both in response to specific drug treatments, mechanical loading of the 
fracture during healing and under pathological conditions that effect healing.  
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INTRODUCTION 
Models of fracture healing are primarily used to evaluate bone repair and 
regeneration after injury. Bone repair requires the recruitment of skeletal progenitor cells 
as a means to lay down cartilage and eventually new bone at the injury sight. These 
skeletal progenitor cells are believed to come from multiple sources including, but not 
limited to, the bone marrow and periosteum (Ozaki 2000). An understanding of the 
recruitment of osteoprogenitor and chondroprogenitor cells and the factors that influence 
their differentiation would be beneficial to the development of skeletal regenerative 
interventions. A significant obstacle has been the unavailability of methods to identify 
these progenitor cells and to track their fate during fracture healing (Grcevic, 2012). In 
this study we generated a transgenic mouse in which we were able to track the fate of 
Prx1-expressing progenitor cells during bone repair.   
Fracture Healing Cascade  Fracture healing is a dynamic process that is characterized by four overlapping 
steps: inflammatory response, formation of soft callus, formation of hard callus, and 
boney union and remodeling. The generation of a fracture disrupts the integrity of the soft 
tissue and this damage initiates the inflammatory response. Bleeding at the fracture site 
into the surrounding tissue leads to the formation of a hematoma and the release of 
cytokines, growth factors, and inflammatory cells. Specifically, interleukins 1 and 6, and 
tumor necrosis factor-α are believed to initiate the repair cascade. The increased 
expression of transforming growth factor β, platelet derived growth factor, fibroblast 
growth factors, insulin-like growth factors, and bone morphogenic proteins are all 
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thought to initiate to one degree or another the recruitment and or progression of 
differentiation of skeletal stem cells and skeletal progenitor cells to promote callus 
formation (Ai-Aql et al., 2008). Formation of the soft callus is characterized by the 
proliferation of fibroblasts and chondrocytes at and near the fracture line. Discrete 
cartilaginous regions grow and converge to form a central fibro-cartilaginous plug that 
binds the two sides of the fracture together. Towards the final stages of formation of the 
soft callus, the chondrocytes undergo hypertrophy and mineralize the cartilage matrix 
before undergoing apoptosis (Schindeler et al., 2008). The formation of the hard callus is 
characterized by the high level of osteoblast activity and the development of mineralized 
bone. The replacement of the cartilaginous soft callus by endochondral ossification is 
initially seen at the proximal and distal margins progressing towards the fracture midline. 
The presence of osteogenic factors differentiates multipotent skeletal stem cells into 
osteo/chondro and osteoprogenitor cells. Osteoprogenitor cells further differentiate into 
mature osteoblasts and synthesize the initial woven bone of the hard callus. Bone 
morphogenic proteins are believed to be the key regulators of this process (Schindeler et 
al., 2008). The final stage of fracture repair is the remodeling of the woven bone into 
lamellar bone, typified by the presence of osteoclasts resorbing woven bone and 
osteoblasts laying down new lamellar bone. This classic four-stage model of fracture 
healing may be altered by mechanical factors and is a fundamental aspect of this study. 
Figure 1 shows histological examples at each stage of the 4-stage model while identifying 
cellular contributors. 
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Figure 1: Four-stage fracture repair model and cellular contributors  
(Schindeler et al., 2008) 
 
The fracture model that we employed involved the generation of a closed, simple, 
transverse fracture by an externally applied blunt trauma. The insertion of an 
intramedullary fixation pin prior to the generation of the fracture provided moderate 
stabilization and allowed micromotion at the fracture site. This micromotion initiated 
repair predominantly through endochondral ossification (Lee et al., 1998). Bone repair 
via endochondral ossification is characterized by the formation of a cartilage intermediate 
and presents as a large callus at the fracture site. The stability of the fracture site 
determines the size of the callus. The less mechanically stable, the larger the callus. The 
more rigid fixation methods that prevent micromotion between cortical bone fragments 
lead to smaller amounts of callus formation (Morgan et al 2010, Thompson et al., 2002).   
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Prx1CreER-GFP-LacZRosa transgenic mouse model 
 The Cre-loxP system has been used for gene manipulation based on site-specific 
recombination catalyzed by the Cre integrase enzyme between two 34-basepair consensus 
recognition sequences. The advantage to this system is that mutation can be triggered 
conditionally instead of leading to ubiquitous expression of the enzyme. In our 
Prx1CreER-GFP-LacZRosa transgenic mouse, the expression of Cre recombinase is 
under the control of a 2.4 kb Prx1 promoter, meaning that the recombination activity 
should only be present in cells that express Prx1 (Kawanami et al., 2009). Recombination 
is achieved when Cre becomes covalently attached to a modified estrogen receptor 
ligand-binding domain creating a fusion protein Cre-ERt. Tamoxifen binds this ERt and 
mediates nuclear translocation and recombination. The recombination allows for the 
transcription of the LacZ gene. The activity of the LacZ on X-gal can be utilized to 
visualize the recombined cells based on the production of a blue product (Maes et al., 
2007). This inducible system allows the Cre-ERt-expressing cells to be tagged upon 
administration of Tamoxifen in a conditional manner in Prx1-expressing cells at a given 
point in time, and to track the subsequent life cycle of the cells that express the tag 
following their migration over time within the callus tissue as it forms.  
Specific Aims/Objectives 
 The goal of the present study is to visualize Prx1-expressing cells during fracture  
healing. Specifically, 
(1) To identify the best staining method for LacZ Rosa to visualize the Prx1-
expressing cells at post-operative day 7. 
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(2) To identify the localization of Prx1-expressing cells at post-operative days 7 
and 14 using the staining method identified to be optimal in aim 1. 
(3) To analyze the mRNA expression of Prx1 compared to other marker genes for 
cartilage and bone formation within the fracture model. 
 It is the hope that this study will elucidate the source and direction of movement 
of Prx1-expressing cells. These results would further explicate the underlying mechanism 
for osteoprogenitor and chondroprogenitor recruitment during fracture healing. 
Understanding the location and signaling of these progenitor cells may help identify cell 
sources and provide a means for harnessing the regenerative capacity of skeletal stem 
cells in bone tissue engineering. 
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METHODS 
Animals & Surgery 
Institutional Animal Care and Use Committee at Boston University approved all 
animal studies. Prx1CreER-GFP transgenic mice were obtained from Case Western 
Reserve University Orthopaedic department, and were bred in house with 129S4–
Gt(Rosa)26 B6 mice (Jackson Laboratories) to produce a Prx1CreER-GFP-LacZRosa 
lineage. The Prx1CreER-GFP-LacZRosa transgenic mutant mice were housed at the 
BUSM animal facility under standard conditions. Prior to aseptic surgery, the 
experimental animals were anesthetized in an anesthesia chamber with a mixture of 
oxygen and isofluorane. Once the mouse was unconscious, it was removed from the 
chamber and a nose cone administering anesthesia was placed over the head of the 
animal. The right knee was shaved with an electric shaver and the animal received 
subcutaneous injections of 0.1 mL Buprenex® to relieve pain and 0.01 mL Baytril® to 
prevent infection immediately prior to surgery. The surgical site was washed with 
Hibiclens® followed by a wash of 70% alcohol starting from the middle working 
outwards. The surgical field was wiped with Betadine. The right leg was bent and with a 
No. 15 scalpel blade, an anterior longitudinal incision was made over the patella in a 
superior to inferior direction. Once the distal femur was exposed, a hole was made in the 
femoral condyle by the insertion of a U-100 27 gauge insulin syringe and was inserted 
the length of the femur to the proximal end. The syringe was removed and the stylette of 
a 25 gauge spinal needle (fixation pin) was inserted the length of the femur. The spinal 
needle stylette was cut at the distal end of the femur with wire cutters and was then 
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buried under the condylar surface with closed forceps. The leg was straightened and the 
incision was closed with two sutures using 5-0 USP Perma Sharp suture material. The 
mouse was placed in the fracture device, the right leg was straightened, and a spring-
loaded blunt blade was released over the mid-diaphyseal shaft to produce a single 
transverse closed fracture. An initial fracture assessment was made by palpation. The 
nose cone was then removed and the animal was positioned for x-ray by a Dental Unit at 
70 kV for 0.10 sec, which utilizes Kodak Ultra Speed DF-50, Size 4 x-rays. The animal 
was transferred to a weighing box, the weight was recorded, and the animal was placed 
on a heating pad to recover. The x-rays were developed in a hand developing box within 
the procedure room to confirm the presence of a fracture. If the x-ray was negative for a 
fracture, the animal was re-anesthetized and another fracture attempt was made at a 
higher setting. This process was continued until a positive fracture x-ray was obtained. If 
a fracture was not obtained after five attempts, the animal did not undergo further fracture 
attempts and was euthanized and excluded from the study. The animals were monitored 
during recovery and were then placed back in their cages after an unrestricted gait was 
observed.      
Tamoxifen 
 Tamoxifen 10 mg/mL solution in corn oil was prepared by combining 11 mL corn 
oil and 110 mg Tamoxifen and sonicating the tube for 3 minutes total with 30 seconds on 
and 5 seconds off. Sonication was repeated until the powder was completely dissolved in 
solution. The solution was then sterilized by filtration through a 0.22 micron sterile 
syringe filter. The Tamoxifen 10 mg/mL solution in corn oil was aliquoted into 2 mL 
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sterile freezing vials and frozen at -20˚C. When ready to use, the freezing vials were 
thawed and the experimental mice were injected 10 µL/g body weight.  
The day 7 experimental animal group received intraperitoneal Tamoxifen 
injections 4 days pre surgery, day 1 and day 3 post surgery. The day 14 experimental 
group received intraperitoneal Tamoxifen injections 4 days pre surgery, day 1, day 3, day 
6, day 8 and day 10 post surgery. Control animals received intraperitoneal injections of 
sterile corn oil according to the same injection schedule as the experimental animals in 
the specified time point. Mice were euthanized at two time points, day 7 and 14 post-
surgery. A flow chart of the study design is shown in figure 2.  
 
Figure 2: Tamoxifen Injection Schedule  
 
Harvest 
The mice were euthanized by carbon dioxide inhalation in a chamber appropriate 
for species, followed by cervical dislocation. A post-mortem x-ray was taken using the 
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Faxitron MX-20 Specimen Radiography System, at 30 kV for 40 seconds, with Kodak 
BioMax XAR Scientific Imaging Film. After euthanasia and post-mortem x-ray, four 
different methods of staining were attempted in order to recover and visualize the highest 
number of Prx1-expressing cells.  
1. Bulk X-gal stain and paraffin embedding 
The right femur was dissected from the experimental mouse and the surrounding soft 
tissue was removed. The fixation pin was carefully removed from the distal end of the 
femur without altering the integrity of the fracture callus. The femur was placed in 4% 
PFA at 4˚C for approximately 1 hour. After 1 hour, the specimen was removed and 
washed for 3 x 30 minutes in X-Gal wash buffer. X-Gal wash buffer was made with 2.0 
mL 1M MgCl2, 10 mL 1% Deoxycholic Acid, 2 mL 10% Nodidet-P40, 23 mL 1M 
Monobasic Sodium Phosphate pH 7.3, 77 mL 1 M Dibasic Sodium Phosphate pH 7.3, 
and 886 mL dH20. After the third 30 minute wash, the wash buffer was removed and 
enough X-Gal stain was added to cover specimen. X-Gal stain must be made fresh in the 
dark with 0.6 mL 50 mg/mL X-Gal in DMF, 1.0 mL 200 mM K-ferrocyanide, 1.0 mL 
200 mM K-ferricyanide, 1.0 mL 1 M Tris pH 7.5, and 46.4 mL wash buffer. The sample 
was developed in the dark covered with foil for 2 days at 4˚C. After 2 days, the stain was 
removed and the sample was washed 3 x 1 hour in 1x PBS. The sample was post-fixed in 
4% PFA at 4˚C overnight. The sample was washed with 1x PBS and kept in 1x PBS until 
further processing.  
 For decalcification, samples were placed in Tissue-Tek© Mega-cassette© and 
submerged in EDTA at 4˚C for 5 days with shaking. After decalcification, the samples 
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were rinsed with distilled water, processed into paraffin using the LEICAASP300 and 
embedded into Paraplast Extra. Samples were stored at 4˚C. Samples were sectioned at 5 
microns and dried overnight at 44˚C in the oven. To stain and cover-slip, samples were 
first deparaffinized 3 x 5 minutes in xylene and rehydrated in 100% EtOH for 5 minutes, 
100% EtOH for 2 minutes, 95% EtOH for 2 minutes, 75% EtOH for 2 minutes, and 
deionized water for 5 minutes. The sample slides were washed in 1x PBS 3 x 5 minutes 
each at room temperature. The slides were stained for 5 minutes in 1% aqueous eosin at 
room temperature and rinsed in distilled water until clear. Slides were allowed to air dry 
and then cover-slipped using Molecular Probes ProLong© Gold Antifade reagent with 
DAPI. 
2. Bulk X-Gal Stain and frozen sectioning 
This staining method was identical to the previous method up until post 
decalcification processing. After the sample was removed from the cold EDTA, it was 
incubated through a series of sucrose gradients starting with 30% sucrose on a rotor at 
4˚C overnight. The sample was then placed in a 1:1 mixture of OCT and 30% sucrose 
under the same conditions for another night. The sample was frozen in cooled liquid 
nitrogen with tetra fluorethane for a rapid freeze and stored at -80˚C.  
After it had been frozen for at least one hour, the sample was sectioned at a thickness 
of 8 microns and placed on a slide. The sample slides were washed in 1x PBS 3 x 5 
minutes each at room temperature. The slides were stained for 5 minutes in 1% aqueous 
eosin at room temperature and rinsed in distilled water until clear. The slides were 
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allowed to air dry and then cover-slipped with Molecular Probes ProLong© Gold 
Antifade reagent with DAPI.   
3. X-Gal Stain of cut frozen sections (Han and Feng 2014). 
This method differs starting at dissection as it was recommended to cut both ends of 
the bone sample for better penetration of the marrow cavity. After dissection, the sample 
was fixed in ice-cold 4% PFA for 1 hour at 4˚C with shaking. The sample was then 
washed in 1x PBS 3 x 30 minutes at 4˚C with shaking. The sample was placed in a 
Tissue-Tek© Mega-cassette© and submerged in 0.1 M EDTA solution at 37˚C overnight 
with shaking. After decalcification, the sample was washed with 1x PBS 3 x 30 minutes 
at room temperature with shaking. The sample was incubated through the same series of 
sucrose gradients as the previous method, embedded in OCT media, and frozen at -
80˚C.The sample was cut at a thickness of 10-12 microns and placed on slides. The 
sections were post-fixed in ice-cold 4% PFA at 4˚C for 10 minutes. The sections were 
washed in 1x PBS 3 x 5 minutes at room temperature and incubated in X-gal solution at 
37˚C for 24 hours while protected from light. The slides were washed in 1x PBS 3 x 5 
minutes, rinsed with distilled water, and counter-stained with 1% aqueous eosin for 5 
minutes. Slides were rinsed with distilled water until clear, allowed to air dry, and cover-
slipped with Molecular Probes ProLong© Gold Antifade reagent with DAPI. 
4. X-Gal Perfusion and frozen sectioning 
Immediately post-mortem, the animal was pinned supine to a Styrofoam surface. 
To expose the heart, the diaphragm was cut and the two sides of the ribcage were pinned 
open. The heart was carefully lifted and the inferior vena cava was clipped. A Vacutainer 
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needle was inserted into the posterior side of the left ventricle and the needle was 
superglued in place. Using a 10 mL syringe, 10 mL of 4% PFA was pushed through the 
Vacutainer tubing, followed by 10 mL of X-gal wash buffer, and 5 mL of X-gal stain. 
The femur was then harvested and post-harvest processing proceeded according to the 
Bulk X-gal stain and frozen sectioning method. 
Imaging 
 High resolution imaging was performed using the Olympus BX51 microscope and 
images were captured using the CellSens software. For each slide, stage limit, shading, 
and white balance calibrations were performed. Images were captured at 10x and stitched 
together in order to include the entire fracture callus at a magnification that cells can be 
discriminated. A 10x stitched image of the same field for each sample was taken in bright 
field and with a DAPI filter. 
 The fracture callus was then delineated into cartilage and ossifying bone. The 
bright field image was used to manually count the number of X-gal stained cells in both 
cartilage and ossifying bone. The DAPI image was used to count the total number of cells 
in the specified regions of cartilage and ossifying bone. The regions of interest were 
manually demarcated and the detection settings were set as such: detection area: ROI, 
borders-frame: truncate, borders-ROI: include, minimum object size: 20 pixels. The 
lower limit of the adaptive threshold varied among samples depending on the intensity of 
staining with the upper limit always at 186. The adaptive threshold range for samples can 
be seen in Table 1. 
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Table 1: Adaptive Threshold Range. This table depicts the adaptive threshold range in 
DAPI when calculating the relative object count of cells. 
 
  Adaptive Threshold 
Slide Lower limit Upper limit 
Paraffin 1 8 186 
Paraffin 2 11 186 
Paraffin 3 18 186 
Bulk Stain Frozen 1 4 186 
Bulk Stain Frozen 2 8 186 
Bulk Stain Frozen 3 8 186 
Han/Feng 1 12 186 
Han/Feng 2 12 186 
Han/Feng 3 12 186 
Perfusion 1 11 186 
Perfusion 2 4 186 
Perfusion 3 4 186 
Han/Feng 4 12 186 
Han/Feng 5 15 186 
Han/Feng 6 15 186 
 
A relative object count was measured and region of interest values were recorded. This 
quantification method was repeated on all samples with n=3. 
 Quantitative real-time polymerase chain reaction analysis  
 Femur samples from C57BL/6J B6 mice (Jackson Laboratories) that underwent 
the same previously described surgery and harvest were used in the gene expression 
analysis. These mice were housed under similar conditions but did not receive corn oil or 
Tamoxifen injections. Post-harvest, femur samples were stored at -80˚C until RNA 
extraction was performed.   
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Femur samples were removed from storage and kept in liquid nitrogen. Each 
sample was then placed in a 2 mL tube filled with 0.75 mL Qiazol Lysis Reagent® and 
flash-frozen in liquid nitrogen for 15 seconds. A 2 mm stainless steel bead was added to 
the 2 mL tube and placed into the Qiagen Tissue Lyser II® for 2 minutes at 30 Hz for 
lysing. If the sample had not homogenized or thawed, the sample was placed back in 
liquid nitrogen and the previous steps were repeated. Once homogenized, the resulting 
solution was removed and added to a tube with 1 mL of Qiazol Lysis Reagent® and put 
on ice. After all samples were lysed, 200 µl of chloroform was added to each sample, 
vortexed, and placed back on ice for at least 2 minutes.  
Each sample was re-vortexed and centrifuged at 14000 RPM at 4° C for 15 
minutes. After centrifugation, the aqueous phase was removed and added to an RNase 
free 1.5 mL tube. An equal volume of isopropanol was added and the tube was inverted 
until the liquid appeared clear. The sample was then centrifuged at 14000 RPM at 4° C 
for 30 minutes and the supernatant was removed and washed with 500 µl of 70% ethanol 
and centrifuged again at 14000 RPM at 4° C for 5 minutes. This process was repeated, 
the ethanol was removed, and the tube was inverted on a sterile Kimwipe to dry. Once 
dry, the pellet was dissolved in 35 µl of RNase-free water and stored at -80° C.  
A quality test of the RNA was performed via electrophoresis on a 2% agarose gel 
at 100V for approximately 40 minutes. The concentration of the RNA was determined by 
adding 1 µL of the diluted RNA to 99 µl of 10 mM Tris buffer and was placed into a 
UV/Vis Spectrophotometer (Beckman Coutler DU 350). Absorbance values of 260 nm 
were recorded.   
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Extracted RNA from each sample was thawed on ice and 2 µg of RNA was 
increased to a volume of 10.4 µL with RNase-free water in a 0.2 mL PCR tube. The 
reverse transcriptase reaction was performed using a mixture of the following reagents 
per sample from the Taqman Reverse Transcription Kit®: 6.61 μL MgCl2, 6.0 μL dNTP 
Mix, 3.0 μL 10X RT Buffer, and 1.5 μL Random Hexamers. The reagents were vortexed 
and the reverse transcriptase enzymes 0.6 μL RNase Inhibitor and 1.89 μL Reverse 
Trancriptase were added to the reagent mixture. The 19.6 μL of the reverse transcription 
polymerase chain reaction reagents and enzymes were added to the 10.4 μL of RNA for a 
total of 30 μL and was lightly mixed. The samples were then placed in a thermal cycler 
(Eppendorf Mastercycler ®) to run the PCR cycle as follows: 25° C for 10 minutes, 37° 
C for 60 minutes, 95° C for 5 minutes, and held at 4° C. The subsequent samples of 
complementary DNA (cDNA) were then diluted 1:50 in RNase-free water and stored at -
20° C until use for qPCR. 
QPCR was performed in order to amplify the DNA primers of interest. For each 
polymerase chain reaction, 9 μL of the diluted cDNA was added to 10 μL of Universal 
PCR Master Mix (Applied Biosystems ®) and 1 μL of the particular primer set (Prx1, 
Gremlin, Sox9, and Osterix). A 96 well plate was used for each reaction and covered with 
a clear adhesive film. The plate was placed into the centrifuge and gently spun down at 
1500 rpm for 2 minutes. The quantitative Real-Time polymerase chain reaction (qRT-
PCR) was performed using an ABI 7700 Sequence Detector® (Applied Biosystems) and 
set up as follows: 50˚C for 2 minutes, 95˚C for 10 minutes, 95˚C for 15 seconds, 60˚C for 
1 minute and run for 40 cycles. Samples were run in duplicate and normalized to 18s 
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rRNA from the same sample. The fold change in expression was normalized to samples 
from non-fractured B6 control mice. 
Statistical analysis was performed using Microsoft Excel 2013 where group 
averages at each time point (n=4) for qPCR data and standard deviations were computed. 
Graphs were produced for mRNA expression of Prx1, Gremlin, Sox9, and Osterix, 
including standard deviation error bars in both directions. 
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RESULTS 
Histological Evaluation of POD7 Staining Methods 
 Figures 3-6 depict representative 10x stitched images in bright field and DAPI 
from each fracture callus at POD7 among the four staining methods: Paraffin, Bulk Stain 
Frozen, Han/Feng, and Perfusion. 
  
Figure 3: 10x Stitched Image of Fracture Callus at POD7 Paraffin Method. A: 
Bright field B: DAPI with total cells counted in red. 
 
 
A 
B 
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Figure 4: 10x Stitched Image of Fracture Callus at POD7 Bulk Stain Frozen 
Method. A: Bright field B: DAPI with total cells counted in red.   
B 
A 
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Figure 5: 10x Stitched Image of Fracture Callus at POD7 Han/Feng Method. A: 
Bright field B: DAPI with total cells counted in red. 
 
A 
B 
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Figure 6: 10x Stitched Image of Fracture Callus at POD7 Perfusion Method. A: 
Bright field B: DAPI with total cells counted in red.  
A 
B 
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A qualitative comparison of the cartilage and newly ossifying bone between the 
different staining methods shows the LacZ stained cells a faded blue in the Paraffin 
method and a more intense blue in the Bulk Stain Frozen, Han/Feng and Perfusion. 
Figure 7 shows examples of the LacZ staining in cartilage and bone at POD7 among the 
four different staining methods. These images are purely for a qualitative comparison and 
are not indicative of the quantitative results. 
 
  
A B 
C D 
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Figure 7: A Comparison of Staining Methods at POD7 in Cartilage and Bone. A: 
Paraffin cartilage B: Paraffin bone C: Bulk Stain Frozen cartilage D: Bulk Stain Frozen 
bone E: Han/Feng cartilage F: Han/Feng bone G: Perfusion cartilage H: Perfusion bone. 
 
 Quantitative analysis of the histological sections at POD7 using the Paraffin 
staining method measures the percentage of LacZ stained cells in cartilage and ossifying 
bone as 0.011% and 0.001% respectively. The Bulk Stain Frozen method produces 
0.034% and 0.021%, the Han/Feng 0.062% and 0.090%, and the Perfusion 0.012% and 
0.007%. Table 2 depicts the cell counts for each sample, group averages, and percentages 
of LacZ stained cells. 
E F 
G H 
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Table 2: Quantitative Comparison of Staining Methods at POD7 in Cartilage and 
Bone.  
POD7 
  Cartilage Bone 
Slide: 
total cartilage 
cells 
LacZ stained 
cells 
total bone 
cells 
LacZ stained 
cells 
Paraffin 1 26336 265 7915 18 
Paraffin 2 22097 236 3512 0 
Paraffin 3 13401 207 4043 5 
Paraffin Average 20611 236 5157 8 
Paraffin % LacZ   0.011   0.001 
Bulk Stain Frozen 1 12009 360 6019 159 
Bulk Stain Frozen 2 11555 426 5462 93 
Bulk Stain Frozen 3 12051 416 5874 107 
Bulk Stain Frozen Average 11872 401 5785 120 
Bulk Stain Frozen % LacZ   0.034   0.021 
Han/Feng 1 13118 872 6245 542 
Han/Feng 2 8875 483 3354 317 
Han/Feng 3 12091 759 5529 504 
Han/Feng Average 11361 705 5043 454 
Han/Feng % LacZ   0.062   0.090 
Perfusion 1 29753 363 5727 31 
Perfusion 2 30442 413 3561 51 
Perfusion 3 26772 264 5643 27 
Perfusion Average 28989 347 4977 36 
Perfusion % LacZ   0.012   0.007 
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Figure 8: Percentage of Cells Stained with LacZ: Comparison of Staining Methods 
at POD7 in Cartilage and Bone. This graph depicts the average number of LacZ stained 
cells in each tissue divided by the total number of cells in that tissue for each staining 
method. 
 
 
Histological Evaluation of Han/Feng POD7 and POD14 Temporal Comparison 
 Figure 9 illustrates a representative 10x stitched image in bright field and DAPI of 
the fracture callus at POD14 using the Han/Feng staining method. 
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Figure 9: 10x Stitched Image of Fracture Callus at POD14 Han/Feng Method. A: 
Bright field B: DAPI with total cells counted in red. 
 
A qualitative comparison of the Han/Feng method at POD7 and POD14 in Figure 
10 shows an increase in the amount of ossifying bone at POD14. The LacZ stained cells 
also appear more spread apart at POD14 than the clustering seen at POD7. The intensity 
of the blue stain appears consistent between the two time points.  
A 
B 
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Figure 10: Temporal Comparison of Han/Feng Method at POD7 and POD14 in 
Cartilage and Bone. A: Cartilage at POD7 B: Bone at POD7 C: Cartilage at POD14 D: 
Bone at POD14. 
 
 A quantitative analysis of the Han/Feng method at POD7 and POD14 indicates an 
increase in the average total number of bone cells to 47,049 and the average LacZ stained 
bone cells to 690 at POD14 from 5,043 and 454 respectively at POD7. There is thus a 
decrease in the percentage of LacZ stained cells at POD14 with 0.015% in bone from the 
0.090% seen at POD7. No cells were stained with LacZ in the cartilage at POD14. Table 
C D 
A B 
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3 reports the cell counts in cartilage and bone of LacZ stained cells compared to the total 
number of cells in each tissue using the Han/Feng staining method at POD7 and POD14. 
 
Table 3: Quantitative Temporal Comparison of Han/Feng Method at POD7 and 
POD14 in Cartilage and Bone. 
 
POD7 
  Cartilage Bone 
Slide 
total cartilage 
cells 
LacZ stained 
cells total bone cells 
LacZ stained 
cells 
Han/Feng 1 13118 872 6245 542 
Han/Feng 2 8875 483 3354 317 
Han/Feng 3 12091 759 5529 504 
Han/Feng Average 11361 705 5043 454 
Han/Feng % LacZ   0.062   0.090 
POD14 
  Cartilage Bone 
Slide 
total cartilage 
cells 
LacZ stained 
cells total bone cells 
LacZ stained 
cells 
Han/Feng 4 8970 0 38930 448 
Han/Feng 5 8648 0 51185 841 
Han/Feng 6 10828 0 51031 781 
Han/Feng Average 9482 0 47049 690 
Han/Feng % LacZ   0.000   0.015 
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Figure 11: Percentage of Cells Stained with LacZ: Temporal Comparison of 
Han/Feng Method at POD7 and POD14 in Cartilage and Bone. This graph depicts the 
average number of LacZ stained cells in each tissue divided by the total number of cells 
in that tissue for each time point. 
 
qPCR Analysis 
 The fold expression of genes associated with cartilage and bone formation was 
analyzed to track the progression of fracture healing. Prx1 is a gene expressed in both 
chondroprogenitor and osteoprogenitor cells, and is thus involved in both chondrogenesis 
and osteogenesis. Figure 12 shows the average fold expression of Prx1 with an absolute 
maximum at day 3 of 14.92 and a relative maximum at day 7 of 9.54. 
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Figure 12: qPCR Analysis of Prx1. This graph shows the temporal gene expression 
profile of Prx1 normalized to 18s rRNA from the same sample. The fold change in 
expression was normalized to non-fractured B6 control mice. 
 
 
Gremlin is a bone morphogenic protein antagonist that has been found to define a 
population of osteochondroreticular stem cells in bone marrow (Worthley et al., 2015). 
Figure 13 shows an average fold expression for Gremlin peaking at day 28 with 1.85 fold 
expression. Still, there is minimal expression of Gremlin throughout this fracture model.  
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Figure 13: qPCR Analysis of Gremlin. This graph shows the temporal gene expression 
profile of Gremlin normalized to 18s rRNA from the same sample. The fold change in 
expression was normalized to non-fractured B6 control mice. 
 
The gene Sox9 produces transcription factors that control the earliest commitment stage 
of chondrogenesis and is seen in early callus formation (Uusitalo et al., 2001). Figure 14 
depicts the average fold expression of Sox9 with an absolute maximum at day 10 of 4.90. 
Minimal expression was detected after day 14.   
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Figure 14: qPCR Analysis of Sox9. This graph shows the temporal gene expression 
profile of Sox9 normalized to 18s rRNA from the same sample. The fold change in 
expression was normalized to non-fractured B6 control mice. 
 
Osterix, produced by the gene OSX, is a transcription factor that is necessary for the 
differentiation of mesenchymal stem cells into osteoblasts and indicates osteoblast 
lineage commitment (Zhang, 2010). Figure 15 shows the average fold expression of 
Osterix with an absolute maximum at day 10 of 29.82.  
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Figure 15: qPCR Analysis of Osterix. This graph shows the temporal gene expression 
profile of Osterix normalized to 18s rRNA from the same sample. The fold change in 
expression was normalized to non-fractured B6 control mice. 
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DISCUSSION 
Histology: Method Comparison 
 At POD7 the frozen histology sections appear superior to the paraffin sections 
when evaluating the presence and brightness of LacZ stained cells. The LacZ stained 
cells in the paraffin sections appear faded and do not present as the bright blue of the 
frozen sections. The processing of paraffin sections requires the use of xylene as well as 
the deparaffinization of the slides for staining. It is known that xylene has a bleaching 
effect on X-gal staining, thus greatly reducing the intensity of the blue staining (Han and 
Feng 2014). The paraffin sections preserve better than the frozen sections, but this fading 
of the LacZ cells diminishes the potential use of the paraffin embedding and sectioning 
method as the best option for the quantification and tracking of Prx1-expressing cells. 
 Another difference in the staining methods was the bulk stain of the X-gal versus 
staining once sectioned. It is difficult to determine at POD7 that this would cause any 
discrepancy. However, at later time points like POD14 or POD21 the X-gal stain may 
have trouble penetrating the callus and staining the deeper portions of the sample. Further 
experimentation would need to be performed to determine whether the staining of cut 
sections is in fact superior to the bulk stain. 
 The Han/Feng staining method required a hot decalcification at 37˚C compared to 
the other methods that were decalcified at 4˚C. A hot decalcification up to 42˚C has been 
experimentally shown as a method of rapid decalcification without any loss of β-
galactosidase activity (Cho et al., 2010). With the large amount of LacZ staining when 
employing the Han/Feng staining method, there is little reason to believe that the hot 
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decalcification method poses a problem to the β-galactosidase activity without further 
experimentation. 
 The Han/Feng staining method also required a hot X-gal stain at 37˚C compared 
to the other methods that were stained in X-gal at 4˚C. It is possible that this method of 
hot staining produced exogenous staining in the bone marrow that was not seen in the 
other staining methods. Further, by performing the staining for 24 hours instead of 4, the 
weaker signals were likely intensified. Further experimentation should be done using the 
Han/Feng method of staining with the X-gal staining at 4 ˚C to determine whether this 
exogenous staining can be eliminated. 
 The Perfusion method did not seem to increase the number of LacZ cells stained 
and is likely unnecessary to the effectiveness of X-gal staining. The decrease in the 
number of stained cells from the Bulk Stain Frozen Method to the Perfusion is probably 
due to the differences in the callus size and variability among animals. One side of the 
cortical bone shell broke off during harvest and the partial sample is a likely contributor 
to the decreased number of LacZ stained cells. It would be expected that the Perfusion 
method produced similar numbers to the Bulk Stain Frozen. 
 
Histology: Temporal Comparison 
 When comparing the Han/Feng method at POD7 and POD14 it is evident that the 
number of ossifying bone cells increases at the later time point, and there are no LacZ 
stained cells in the cartilage at the later time point. The first observation is expected with 
the normal progression of fracture healing. The increase in the number of LacZ stained 
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cells in the bone at POD14 suggests that the Prx1 cell population in the periosteum either 
continues to give rise to the initial primary bone in the callus or the progeny of the 
original cells that developed in the callus have continued to expand in the primary bone 
that develops at the later time period. It is interesting to note that the former possibility is 
favored based on the second broad peak of Prx1 mRNA expression that was seen in the 
callus tissues extending from 7 days through 14 days post-operative (see discussion 
below). The second observation that no LacZ stained cells were seen in the cartilage at 
POD14 was not as expected. However, it is possible that the tagged chondrocytes that 
arose initially after fracture had already remodeled at POD14 and are thus not seen. The 
mRNA data is also suggestive of this conclusion since Prx1 showed a very strong peak of 
expression at POD 3 and it is the cells expressing the Prx1 at this time that most likely 
became tagged in the callus at day 7. The implication of this finding is that the Prx1 cells 
at earlier and later times are solely directed into either cartilage or bone lineages at these 
two different times during fracture healing. Further experimentation restricting the Prx1 
induction period to either earlier or later time points needs to be done on more animals to 
further explore this suggestive data.  
 
Gene Expression 
 Prx1 gene expression peaks at day 3 and 7 in this fracture model. This is 
consistent with the known expression of Prx1 in the periosteum in chondroprogenitor and 
osteoprogenitor cells. It is probable that the day 3 peak is indicative of the recruitment of 
chondroprogenitor cells to begin formation of the soft callus. The day 7 peak may 
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indicate the recruitment of osteoprogenitor cells to begin the formation of the hard callus. 
The Prx1 average fold expression remains elevated during the remainder of fracture. 
 Gremlin gene expression does not appear to be affected by fracture as the average 
fold expression never exceeds 2. It is interesting to note that it approaches the levels seen 
in native unfractured bone. This suggests that as the marrow is established in the callus at 
later times, these stem cells populate the new marrow space of the healing bone. Sox9 
and Osterix average fold expression both peak at day 10 and are indicative of early callus 
formation. 
 
Future Directions 
 Once the histological methods are finalized for this study, Tamoxifen will be 
administered in specific time windows to better track the fate of the Prx1-expressing 
cells. It is the ultimate goal that the Prx1CreER-GFP-LacZRosa lineage will be used for 
further experimentation with distraction osteogenesis.    
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